Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

ZOLMITRIPTAN TABLET

Awarded
SPE2DP22F2339Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Defense Logistics Agency award SPE2DP22F2339 is a delivery order issued under contract SPE2DX15D9383 to DMS Pharmaceutical Group Inc for the procurement of Zolmitriptan tablets, identified by NSN 6505015230353. The contract falls under NAICS code 325412 and was managed by DLA Troop Support, incorporating standard federal acquisition regulations and defense priority and allocations system ratings. Modification P00001 subsequently resulted in the total cancellation of CLIN 0001. This action was taken due to vendor non-performance and the decommissioning of ships, which rendered the aged delivery orders unnecessary. This modification decreased the total contract amount by 1,480.17 dollars, bringing the final contract balance to zero dollars.

General Info

DLA cancelled Zolmitriptan tablet order SPE2DP22F2339 due to non-performance and ship decommissioning.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

2
PDF, High priority: read this firstmodification
High
PDF, High priority: read this firstrfp
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP22F2339 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: See Award Doc Award Date: 08-25-2026 Delivery order under: SPE2DX15D9383 Line items: - ZOLMITRIPTAN TABLET (NSN/Part 6505015230353)

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-27-T-0233
Solicitation SPE2DP-27-T-0233, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the procurement of Dibucaine Ointment, USP. The required product is a rectal ointment containing 1 percent dibucaine as the active ingredient, supplied in a collapsible tube with a rectal applicator. Each unit of issue consists of one package containing one ounce or 28 grams. The product must be stored between 15 and 30 degrees Celsius and is intended for external, rectal administration. The procurement specifies a quantity of one package with a required delivery date of November 5, 2026, and a delivery lead time of 20 days after order. The contract mandates strict adherence to quality and packaging standards, including USP standards, MIL-STD-129 for marking, and Medical Marking Standard No. 1. Packaging must comply with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951 for non-hazardous materials, while hazardous materials must follow TQ requirement IP025 and FED-STD-313. Delivery is FOB Destination, with inspection and acceptance also occurring at the destination. Payment and receiving reports must be processed electronically through the Wide Area WorkFlow (WAWF) system. Key regulatory and legal requirements include compliance with the Buy American Act, the Berry Amendment, and DFARS regulations regarding the safeguarding of covered defense information and the prohibition of certain telecommunications equipment. Offerors must be registered in the System for Award Management (SAM) and provide necessary representations and certifications regarding their business size and socioeconomic status. Quotations are to be submitted via the DIBBS portal by November 9, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS